Thus, the variant could potentially act as a meaningful ancestral-specific genetic biomarker to guide precision medicine strategies of not only metformin treatment in type 2 diabetes, but also other drugs that are known to be transported by OCT3. Here, SLC22A3 is linked to type 2 diabetes mellitus.